HOME >> BIOLOGY >> NEWS
Aldo Leopold leadership program moves to Stanford University and awards new fellowships for 2005

The Aldo Leopold Leadership Program, which trains academic environmental scientists to communicate effectively to non-scientists, has relocated to Stanford University. The program had been based at the New England Aquarium in Boston before joining the Stanford Institute for the Environment earlier this year.

Debbie Drake Dunne, former director of government relations for the Nature Conservancy of California, has been appointed the new executive director of the program.

"The Leopold Leadership Program is a unique and exciting program, and we are proud to have it become part of the Stanford Institute for the Environment," said Pamela Matson, the Chester Naramore Dean of the Stanford School of Earth Sciences and co-chair of the program steering committee.

In addition to announcing the move to Stanford, program officials also released the names of 19 environmental scientists who have been awarded Aldo Leopold Fellowships for 2005. Each fellow will receive intensive training on communicating environmental science to policymakers, the media, business leaders and the public. This year's fellows represent a broad range of environmental science disciplines, including forest ecology, sustainable agriculture, environmental engineering and oceanography. A complete list of all 99 fellowship recipients, past and present, is available at http://www.leopoldleadership.org.

"The 2005 cohort of Leopold Leadership Fellows comprises a truly outstanding group of scientists working to address today's most important environmental challenges," said program founder and steering committee co-chair Jane Lubchenco, Distinguished Professor of Zoology at Oregon State University.

Founded in 1998 with funding from the David and Lucile Packard Foundation, the program is named for Aldo Leopold, a prominent environmental scientist whose writings, including his 1949 book, A Sand County Almanac, are credited with infu
'"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
650-723-9296
Stanford University
28-Mar-2005


Page: 1 2 3

Related biology news :

1. Eighteen researchers selected as 2006 Aldo Leopold Leadership Fellows
2. Group decisions: From compromise to leadership in pigeon homing
3. UK e-Science Program wins award for leadership in grid computing
4. ESA calls for federal leadership to control invasive species
5. Boston University biologist honored for leadership in estuarine education
6. BioMed Central applauds Wellcomes leadership on Open Access
7. AAAS honors recombinant DNA advisory committee at NIH, citing 30 years of leadership
8. New data reveal pregnancies exposed to accutane despite risk management program
9. 50 new mission proposals for ESAs scientific program
10. UD awarded $11M for osteoarthritis research and unique mentoring program for women scientists
11. ESAs water mission instrument passes test program

Post Your Comments:
(Date:8/19/2015)...  VOXX International Corporation (Nasdaq: VOXX ) ... Definitive Agreement to purchase the assets, inclusive of ... EyeLock through an acquiring entity.  Upon consummation of ... in the acquiring entity. The closing of the ...  Expanding on its existing supply chain and distribution ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
(Date:9/2/2015)... -- Biovista Inc. is glad to announce ... science challenge, a global competition hosted by the Rare ... the latest life science innovations and technologies. ... capability to support Steven Laffoon and his ... Niemann-Pick Disease Type A (NPA), a rare and fatal ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... -- Aytu BioScience, Inc. (OTCQB: AYTU), a specialty healthcare ... conditions, announced today that it has closed the final ... raising a total of $5.175 million, which includes proceeds ... Josh Disbrow , Chief Executive Officer of ... to be used to conduct clinical studies for both ...
(Date:9/2/2015)... , September 2, 2015 ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, announced today that presentations highlighting ... will be delivered at the Ophthalmology Futures European ... Society of Cataract & Refractive Surgeons ("ESCRS"), both ...
Breaking Biology Technology:Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
Cached News: